SCHEMBL3277910

SCHEMBL3277910

CCCCNc1nc(-c2ccccn2)cc(Cl)c1-c1c(F)cccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 12/20 0.42
MERTK Q12866 12/20 0.42
FLT3 P36888 9/20 0.42
GAS6 Q14393 9/20 0.42
AXL P30530 8/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
GPR39 O43194 1/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
PPP1CA P62136 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NR4A2 P43354 1/20 0.38
CCNT1 O60563 1/20 0.38
TLR8 Q9NR97 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3279741 0.84 NR4A2 (0.42) TYRO3MERTKFLT3GAS6AXL
SCHEMBL3277906 0.81 MEN1 (0.45) L3MBTL1CCR1CCR5CCR8GPR39
SCHEMBL13385481 0.81 CCR1 (0.43) L3MBTL1KDM4ECCR1CCR5CCR8
SCHEMBL13385501 0.80 MAPK1 (0.54) KDM4ENPSR1NPC1HTTSMN1; SMN2
SCHEMBL13385479 0.78 CCR1 (0.39) L3MBTL1CCR1CCR5CCR8GPR39
SCHEMBL13385470 0.78 SOS1 (0.41) CCR1CCR5CCR8
SCHEMBL13385465 0.77 JAK2 (0.41) L3MBTL1KDM4ECCR1CCR5CCR8
SCHEMBL3280715 0.77 CCR1 (0.51) L3MBTL1KDM4ECCR1CCR5CCR8
SCHEMBL13385476 0.76 GPR39 (0.47) TYRO3MERTKFLT3GAS6AXL
SCHEMBL14086459 0.74 TLR8 (0.39) L3MBTL1KDM4ENPSR1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7695728-B2 2-substituted pyridines, processes for their preparation and their use for controlling harmful fungi BASF AKTIENGESELLSCHAFT (DE) 2010-04-13 US disclosed
US-20070259919-A1 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi BASF AKIENGESELLSCHAFT (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259919-A1 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi CYP4X1, CYCS, CYP2S1 TYRO3 600/4885MERTK 3823/4885FLT3 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.